Kodiak Sciences, Inc. (KOD)
37.83
-1.29
(-3.30%)
USD |
NASDAQ |
Aug 28, 13:15
Kodiak Sciences Debt to Equity Ratio : 2.500 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.500 |
| March 31, 2026 | 1.392 |
| December 31, 2025 | 1.011 |
| September 30, 2025 | 6.846 |
| June 30, 2025 | 2.350 |
| March 31, 2025 | 1.540 |
| December 31, 2024 | 1.134 |
| September 30, 2024 | 0.9356 |
| June 30, 2024 | 0.8194 |
| March 31, 2024 | 0.7393 |
| December 31, 2023 | 0.6834 |
| September 30, 2023 | 0.6067 |
| June 30, 2023 | 0.5459 |
| March 31, 2023 | 0.4757 |
| December 31, 2022 | 0.4304 |
| September 30, 2022 | 0.3917 |
| June 30, 2022 | 0.3522 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.3036 |
| December 31, 2021 | 0.2713 |
| September 30, 2021 | 0.2463 |
| June 30, 2021 | 0.2286 |
| March 31, 2021 | 0.0945 |
| December 31, 2020 | 0.0899 |
| September 30, 2020 | 0.2744 |
| June 30, 2020 | 0.0056 |
| March 31, 2020 | 0.0056 |
| December 31, 2019 | 0.0056 |
| September 30, 2019 | 0.0341 |
| June 30, 2019 | 0.0305 |
| March 31, 2019 | 0.0284 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -1.061 |
| March 31, 2018 | |
| December 31, 2017 | -0.6203 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 256.81M |
| Total Liabilities (Quarterly) | 195.72M |
| Shareholders Equity (Quarterly) | 61.10M |
| Current Ratio | 2.489 |
| Net Debt Paydown Yield | 0.12% |